HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunosuppressive therapy for pemphigus vulgaris complicated by malakoplakia of the bladder.

Abstract
Pemphigus vulgaris is an uncommon auto-immune disease which responds well to treatment with corticosteroids and azathioprine. Malakoplakia is a rare granulomatous disease associated with coliform infections and an altered cellular immune response. We report a 68-year-old female patient with pemphigus vulgaris who, after 2 years on maintenance prednisone and azathioprine immunotherapy, developed malakoplakia of the bladder associated with chronic E. coli urinary-tract infection. The malakoplakia responded well to treatment with cotrimoxazole, bethanechol chloride and ascorbic acid, combined with tapering of the corticosteroid dosage. Our patient presents an uncommon but interesting complication of long-term immunosuppressive therapy for pemphigus vulgaris.
AuthorsH F Jordaan, C F Heyns, F J Allen, J Schneider
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 15 Issue 6 Pg. 442-5 (Nov 1990) ISSN: 0307-6938 [Print] England
PMID2279343 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Prednisolone
  • Azathioprine
Topics
  • Aged
  • Azathioprine (adverse effects, therapeutic use)
  • Escherichia coli Infections (complications)
  • Female
  • Humans
  • Immunosuppression Therapy (adverse effects)
  • Malacoplakia (etiology, pathology)
  • Pemphigus (complications, pathology, therapy)
  • Prednisolone (adverse effects, therapeutic use)
  • Urinary Bladder Diseases (etiology, pathology)
  • Urinary Tract Infections (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: